Company Filing History:
Years Active: 2021
Title: Christopher Taus: Innovator in Immunogenic Compositions
Introduction
Christopher Taus is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, particularly in the development of innovative compositions for treating Her2/neu positive tumor diseases. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
One of his latest patents is an immunogenic composition that includes a directed adjuvant and an immunogen linked to specific peptidic alpha-helices. This invention aims to enhance the immune response against Her2/neu positive tumors. Another significant patent is a coiled-coil connector designed to connect two molecules through helical structures. This connector can be utilized in multimeric proteins, showcasing the versatility of his inventions.
Career Highlights
Christopher Taus is currently associated with Oncoqr ML GmbH, where he continues to innovate in the field of immunotherapy. His work is characterized by a strong focus on developing effective treatments for cancer, particularly through the use of immunogenic compositions.
Collaborations
He collaborates with esteemed colleagues such as Geert Mudde and Jorge Sepulveda, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Christopher Taus is a prominent figure in the field of immunology, with a focus on developing groundbreaking treatments for cancer. His patents reflect his commitment to advancing medical science and improving patient outcomes.